Potential Mechanism ID'd for Impact of Parity on Pelvic Floor

This article originally appeared here.
Share this content:
Potential Mechanism ID'd for Impact of Parity on Pelvic Floor
Potential Mechanism ID'd for Impact of Parity on Pelvic Floor

WEDNESDAY, Sept. 14, 2016 (HealthDay News) -- Parity is associated with increased fiber length in the more proximal coccygeus and iliococcygeus pelvic floor muscles, according to a study published in the September issue of the American Journal of Obstetrics and Gynecology.

Marianna Alperin, M.D., from the University of California in San Diego, and colleagues examined the impact of vaginal deliveries and aging on human cadaveric pelvic floor muscle architecture. They obtained coccygeus, iliococcygeus, and pubovisceralis from younger and older donors, who were vaginally parous and vaginally nulliparous, all of whom had no history of pelvic floor disorders. Validated methods were used to assess architectural parameters.

The researchers found that the key impact of parity was increased fiber length in the more proximal coccygeus and iliococcygeus (P = 0.03 and 0.04, respectively). Across all pelvic floor muscles, aging changes manifested as decreased physiologic cross-sectional area (P < 0.05), which exceeded the age-linked decline in muscle mass. Younger vaginally parous pelvic floor muscles had lower physiologic cross-sectional area compared with younger vaginally nulliparous; the difference did not reach statistical significance. Collagen content of pelvic floor muscles was not altered by parity but increased with aging (P < 0.05).

"Increased fiber length in more proximal pelvic floor muscles likely represents an adaptive response to the chronically increased load placed on these muscles by the displaced apical structures, presumably as a consequence of vaginal delivery," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease



Sign up for myCME e-newsletters


More in Home

AAN: Erenumab Shows Promise for Hard-to-Treat Migraine

AAN: Erenumab Shows Promise for Hard-to-Treat Migraine

Higher proportion of patients achieved a ≥50 percent reduction in mean monthly migraine days

AAN: New Drug May Help Infants With Spinal Muscular Atrophy

AAN: New Drug May Help Infants With Spinal ...

RG7916 increases survival motor neuron protein level, with 6.5-fold increase noted with highest dose

Small Link for Cannabis Use, Reduced Cognitive Functioning

Small Link for Cannabis Use, Reduced Cognitive Functioning

Small overall effect size for frequent and heavy cannabis use among adolescents, young adults

is free, fast, and customized just for you!

Already a member?

Sign In Now »